MRSN stock results show that Mersana Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
Articles
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q2 2024
MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
CIFR Stock Earnings: Cipher Mining Beats EPS, Misses Revenue for Q2 2024
CIFR stock results show that Cipher Mining beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
ABOS Stock Earnings: Acumen Pharmaceuticals Misses EPS for Q2 2024
ABOS stock results show that Acumen Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024. More
CMRX Stock Earnings: Chimerix Meets EPS, Beats Revenue for Q2 2024
CMRX stock results show that Chimerix met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
CCLD Stock Earnings: CareCloud Beats EPS, Misses Revenue for Q2 2024
CCLD stock results show that CareCloud beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
MRNS Stock Earnings: Marinus Pharma Misses EPS, Misses Revenue for Q2 2024
MRNS stock results show that Marinus Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
